Your client is a leading pharmaceutical company that is facing challenges with increasing pipeline costs and longer development timelines for their drug candidates. The company has multiple drug candidates in various stages of development and are looking for innovative strategies to streamline their processes and reduce costs without compromising the quality and safety of their products.
How would you approach identifying the main drivers of these increased costs and extended timelines?
This is a Mckinsey-style (interviewer-led case). You need to drive the case forward and prompt the candidate with questions.